高齢者のフェリックカルボキシマルトース投与の評価:臨床的結果,異なるケア環境における比較特性,費用分析. 5年間の研究
María Noemí García-Calderón Díaz1, Antonio Medina Nieto1, Mateo Ballesteros Arana1
1Servicio de Geriatría, Hospital Central de la Cruz Roja San José y Santa Adela, Madrid, Spain.
Revista espanola de geriatria y gerontologia
|August 29, 2025
まとめ
鉄炭酸カルボキシマルトースは,高齢者のための安全で効果的な静脈内鉄治療です. 自宅や介護施設での治療は費用対効果が高く,医療へのアクセスを改善し,医療費を削減します.
科学分野:
- 高齢者医療
- 薬理学について
- 健康 経済
背景:
- 鉄欠乏性貧血は高齢者に多く見られる.
- 静脈内鉄炭酸カルボキシマルトースは,治療のためにますます使用されています.
- 様々な介護環境での使用を評価することが重要です.
研究 の 目的:
- 高齢患者における鉄炭酸カルボキシマルトースの安全性と有効性を評価する.
- 異なる介護環境での費用対効果を評価する.
- 5年間の臨床結果と副作用を分析する.
主な方法:
- 198人の高齢者を対象とした遡及観察コホート研究.
- 患者の人口統計,臨床的要因,および副作用に関するデータ
- 高齢者デイ・ホスピタルの管理と自宅/介護施設の設定を比較したコスト分析
主要な成果:
- 治療は一般的に安全で,軽度の副作用 (5. 73%) が主に血圧に影響しました.
- 介護施設の患者は 弱体化や併発症率が高かった
- 老人ホームの入院ユニットによる管理は,潜在的に39,353.80ユーロの節約を示しました.
結論:
- 鉄炭酸カルボキシマルトースは,弱い高齢の患者にとって安全で有効です.
- 家庭や介護施設の管理は費用対効果的です.
- このアプローチにより 医療へのアクセシビリティが向上し 医療費が削減できます
関連する概念動画
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


